CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

作者: Yvette W.J. Paulis , Elisabeth J.M. Huijbers , Daisy W.J. van der Schaft , Patricia M.M.B. Soetekouw , Patrick Pauwels

DOI: 10.18632/ONCOTARGET.3839

关键词:

摘要: Aggressive tumor cells can obtain the ability to transdifferentiate into with endothelial features and thus form vasculogenic networks. This phenomenon, called mimicry (VM), is associated increased malignancy poor clinical outcome. To identify novel key molecules implicated in process of mimicry, microarray analysis was performed compare gene expression profiles aggressive (VM+) non-aggressive (VM-) derived from Ewing sarcoma breast carcinoma. We identified CD44/c-Met signaling cascade as heavily relevant for mimicry. CD44 at center this cascade, highly overexpressed tumors. Both standard isoform its splice variant CD44v6 were linked aggressiveness VM. Since VM most abundant tumors functional analyses EW7 cells. Overexpression allowed enhanced adhesion extracellular matrix ligand hyaluronic acid. also facilitated formation structures vitro, knockdown experiments repressed migration vascular network formation. From these results observation that blood lakes human tissues, we conclude increases through

参考文章(47)
Arjan W. Griffioen, Marieke J.H. Coenen, Cora A. Damen, Sandra M.M. Hellwig, David H.J. van Weering, Wim Vooys, Geert H. Blijham, Gerard Groenewegen, CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells Blood. ,vol. 90, pp. 1150- 1159 ,(1997) , 10.1182/BLOOD.V90.3.1150
Richard E.B. Seftor, Angela R. Hess, Elisabeth A. Seftor, Dawn A. Kirschmann, Katharine M. Hardy, Naira V. Margaryan, Mary J.C. Hendrix, Tumor Cell Vasculogenic Mimicry: From Controversy to Therapeutic Promise American Journal of Pathology. ,vol. 181, pp. 1115- 1125 ,(2012) , 10.1016/J.AJPATH.2012.07.013
David Naor, Ronit Vogt Sionov, Dvorah Ish-Shalom, CD44: Structure, Function and Association with the Malignant Process Advances in Cancer Research. ,vol. 71, pp. 241- 319 ,(1997) , 10.1016/S0065-230X(08)60101-3
Jayne Lesley, Robert Hyman, Paul W. Kincade, CD44 and its interaction with extracellular matrix. Advances in Immunology. ,vol. 54, pp. 271- 335 ,(1993) , 10.1016/S0065-2776(08)60537-4
Simona Corso, Paolo M. Comoglio, Silvia Giordano, Cancer therapy: can the challenge be MET? Trends in Molecular Medicine. ,vol. 11, pp. 284- 292 ,(2005) , 10.1016/J.MOLMED.2005.04.005
YUN-LONG FAN, MIN ZHENG, YA-LING TANG, XIN-HUA LIANG, A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review) Oncology Letters. ,vol. 6, pp. 1174- 1180 ,(2013) , 10.3892/OL.2013.1555
Ursula Günthert, Martin Hofmann, Wolfgang Rudy, Sonja Reber, Margot Zöller, Irmgard Hauβmann, Siegfried Matzku, Achim Wenzel, Helmut Ponta, Peter Herrlich, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell. ,vol. 65, pp. 13- 24 ,(1991) , 10.1016/0092-8674(91)90403-L
Heribert Jürgens, Uta Dirksen, Ewing sarcoma treatment. European Journal of Cancer. ,vol. 47, ,(2011) , 10.1016/S0959-8049(11)70206-4
Peter Carmeliet, Rakesh K. Jain, Molecular mechanisms and clinical applications of angiogenesis Nature. ,vol. 473, pp. 298- 307 ,(2011) , 10.1038/NATURE10144
Yvette W.J. Paulis, Patricia M.M.B. Soetekouw, Henk M.W. Verheul, Vivianne C.G. Tjan-Heijnen, Arjan W. Griffioen, Signalling pathways in vasculogenic mimicry Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. ,vol. 1806, pp. 18- 28 ,(2010) , 10.1016/J.BBCAN.2010.01.001